Beta-2-microglobulin is used in the diagnosis of active rheumatoid arthritis and kidney disease [29], [30], and a structural variant of b2m has been associated with autoimmune disease and small-cell lung cancer [31], [32]. Here, B2M is linked to kidney disorder.